Natera Inc (NAS:NTRA)
$ 124.39 0.95 (0.77%) Market Cap: 15.38 Bil Enterprise Value: 14.82 Bil PE Ratio: 0 PB Ratio: 18.35 GF Score: 72/100

Natera Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 13, 2021 / 03:45PM GMT
Release Date Price: $120.25 (+0.08%)
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

Hey, everyone. Good morning. Thanks for joining us on day 3 of our healthcare conference. I'm Tejas Savant, and I cover the life science tools and diagnostics sector here at Morgan Stanley. Delighted to have Natera join us today. And representing the company, we have Steve Chapman, CEO; and Mike Brophy, CFO. Thanks for joining us, guys.

Steve Chapman
Natera, Inc. - CEO, President & Director

Sure.

Questions & Answers

Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

For important disclosures before we get to the Q&A, please see the research disclosure website at morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your sales rep. With that out of the way, Steve, let's get right to it, a lot of ground to cover this morning.

So maybe I'll start on the Prospera side of things where you have the most exciting news recently on the launch of heart transplant

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot